Light-based drug delivery for sarcoma treatment
Part of Cancer clinical trials.
This trial tests a new light-based drug delivery system to treat sarcomas. It looks at how well this platform works during surgery or biopsy for patients with soft tissue or bone sarcomas.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 0 and 85 years old.
- You have a soft tissue sarcoma or bone sarcoma (including osteosarcoma).
- You are having surgery or a biopsy for the sarcoma.
- You may have had or be currently getting chemotherapy, targeted therapy, radiation, or a mix of these.
- If you are being treated at the Istituto Ortopedico Rizzoli, you will need to sign two consent forms. At IRST, adult patients only need to sign one.
- You do not have multiple primary tumors.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a special medication (5-ALA) before surgery makes the sarcoma glow under a special light, helping the surgeon see and remove the cancer more completely. The goal is to reduce the chance of leaving any cancer behind.
This trial tests an experimental drug, SOT106, that targets a specific marker on sarcoma cells. It aims to see if the drug is safe and effective in treating advanced osteosarcoma or soft tissue sarcoma when other treatments have not helped.
This trial tests a new drug, HS-20093, combined with other treatments for people with advanced bone or soft tissue sarcoma. The goal is to see if these combinations can shrink tumors or slow their growth.
This trial tests a combination of radiation therapy and two drugs (anlotinib and penpulimab) given before surgery for soft tissue sarcoma. The goal is to see if this approach can shrink tumors and improve outcomes.
This trial tests a personalized (“adaptive”) radiation plan before surgery for high-grade soft-tissue sarcoma that can be removed. It may help shrink the tumor and improve how well surgery can treat the cancer.
This trial studies a high-dose, shortened course of proton beam radiation for people with soft tissue sarcoma that cannot be removed by surgery. It aims to improve tumor control while reducing side effects.
Hear when a new Bone and Soft Tissue Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.